Formulation and Optimization of Eudragit RS PO-Tenofovir Nanocarriers Using Box-Behnken Experimental Design

about

Formulation and Optimization of Eudragit RS PO-Tenofovir Nanocarriers Using Box-Behnken Experimental Design

Item

http://www.wikidata.org/entity/Q59113900

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2015

@uk

name

Formulation and Optimization o ...... ox-Behnken Experimental Design

@en

Formulation and Optimization o ...... ox-Behnken Experimental Design

@nl

type

Item

label

Formulation and Optimization o ...... ox-Behnken Experimental Design

@en

Formulation and Optimization o ...... ox-Behnken Experimental Design

@nl

prefLabel

Formulation and Optimization o ...... ox-Behnken Experimental Design

@en

Formulation and Optimization o ...... ox-Behnken Experimental Design

@nl

P1476

Formulation and Optimization o ...... ox-Behnken Experimental Design

@en

P2093

Gertrude Makgatho

http://www.w3.org/2001/XMLSchema#string

Indra Bahadur

http://www.w3.org/2001/XMLSchema#string

Kefilwe Matlhola

http://www.w3.org/2001/XMLSchema#string

Lebogang Katata-Seru

http://www.w3.org/2001/XMLSchema#string

Lesego Tshweu

http://www.w3.org/2001/XMLSchema#string

Mohammed Balogun

http://www.w3.org/2001/XMLSchema#string

P2860

Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues.

Polymer-based nanocapsules for drug delivery.

Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission

Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention.

Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.

Spray drying tenofovir loaded mucoadhesive and pH-sensitive microspheres intended for HIV prevention.

Optimization of hydrogels for transdermal delivery of lisinopril by Box-Behnken statistical design

Tenofovir: what have over 1 million years of patient experience taught us?

Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/630690

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

nanocarrier